In light of these genetic interactions, a growth advantage could be conferred to tumor cells that overexpress SHH through interaction with currently unknown growth promoting targets, while at the same time abrogating OLIG1 expression concomitant to MAG down-regulation. Here, MAG is linked to neoplasm.